Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cihan Ay

Showing results (271-280 of 344) with videos related to

Pageof 35
Sort By:
Cancers|December 19, 2019
Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) are Associated with a High Risk of Venous Thromboembolism in Patients with GliomaPegah Mir Seyed Nazari, Christine Marosi, Florian Moik, et al.
Blood|January 29, 2021
Natural IgM antibodies inhibit microvesicle-driven coagulation and thrombosisGeorg Obermayer, Taras Afonyushkin, Laura Göderle, et al.
Thrombosis and Haemostasis|February 21, 2022
Outcome of Cancer-Associated Venous Thromboembolism Is More Favorable among Patients with Hematologic Malignancies than in Those with Solid TumorsRamón Lecumberri, Pedro Ruiz-Artacho, Inna Tzoran, et al.
Thrombosis Research|October 7, 2015
Integrin beta-3 genetic variants and risk of venous thromboembolism in colorectal cancer patientsDaniela Bianconi, Alexandra Schuler, Clemens Pausz, et al.
Journal of Thrombosis and Haemostasis : JTH|June 5, 2025
Clinical evidence for antiglycoprotein IIbIIIa antibody-induced platelet desialylation in primary immune thrombocytopeniaTheresa Schramm, Jan Zlamal, Jasmin Rast, et al.
ESMO Open|May 20, 2020
Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with gliomaPegah Mir Seyed Nazari, Anna S Berghoff, Matthias Preusser, et al.
Scientific Reports|August 29, 2025
Podoplanin expression is associated with local inflammation and survival in gliomaPegah Mir Seyed Nazari, Maximilian J Mair, Julia Riedl, et al.
Journal of Thrombosis and Haemostasis : JTH|February 20, 2020
Influence of blood group, von Willebrand factor levels, and age on factor VIII levels in non-severe haemophilia AJudit Rejtő, Oliver Königsbrügge, Ella Grilz, et al.
Journal of Thrombosis and Haemostasis : JTH|August 30, 2024
Fibrinolysis is impaired in patients with primary immune thrombocytopeniaTheresa Schramm, Jasmin Rast, Dino Mehic, et al.
Blood Advances|January 26, 2021
Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancerYohei Hisada, Kenison B Garratt, Anaum Maqsood, et al.
Pageof 35

Showing results (271-280 of 344) with videos related to

Sort By:
Pageof 35
Cancers|December 19, 2019
Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) are Associated with a High Risk of Venous Thromboembolism in Patients with GliomaPegah Mir Seyed Nazari, Christine Marosi, Florian Moik, et al.
Blood|January 29, 2021
Natural IgM antibodies inhibit microvesicle-driven coagulation and thrombosisGeorg Obermayer, Taras Afonyushkin, Laura Göderle, et al.
Thrombosis and Haemostasis|February 21, 2022
Outcome of Cancer-Associated Venous Thromboembolism Is More Favorable among Patients with Hematologic Malignancies than in Those with Solid TumorsRamón Lecumberri, Pedro Ruiz-Artacho, Inna Tzoran, et al.
Thrombosis Research|October 7, 2015
Integrin beta-3 genetic variants and risk of venous thromboembolism in colorectal cancer patientsDaniela Bianconi, Alexandra Schuler, Clemens Pausz, et al.
Journal of Thrombosis and Haemostasis : JTH|June 5, 2025
Clinical evidence for antiglycoprotein IIbIIIa antibody-induced platelet desialylation in primary immune thrombocytopeniaTheresa Schramm, Jan Zlamal, Jasmin Rast, et al.
ESMO Open|May 20, 2020
Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with gliomaPegah Mir Seyed Nazari, Anna S Berghoff, Matthias Preusser, et al.
Scientific Reports|August 29, 2025
Podoplanin expression is associated with local inflammation and survival in gliomaPegah Mir Seyed Nazari, Maximilian J Mair, Julia Riedl, et al.
Journal of Thrombosis and Haemostasis : JTH|February 20, 2020
Influence of blood group, von Willebrand factor levels, and age on factor VIII levels in non-severe haemophilia AJudit Rejtő, Oliver Königsbrügge, Ella Grilz, et al.
Journal of Thrombosis and Haemostasis : JTH|August 30, 2024
Fibrinolysis is impaired in patients with primary immune thrombocytopeniaTheresa Schramm, Jasmin Rast, Dino Mehic, et al.
Blood Advances|January 26, 2021
Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancerYohei Hisada, Kenison B Garratt, Anaum Maqsood, et al.
Pageof 35